Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phoenix Pharmaceuticals, Inc. is a specialized biotechnology company focused on the research, development, and manufacture of neuropeptides and related assay kits. Headquartered in Burlingame, California, the company offers an extensive portfolio of over 7,000 products, including ELISA kits, radioimmunoassay (RIA) kits, and high-purity peptides. Their products are widely utilized in global research for metabolic disorders, cardiovascular health, and neuroscience. In addition to its catalog offerings, Phoenix Pharmaceuticals provides custom peptide synthesis and antibody production services to support drug discovery and academic research. The company is recognized for its expertise in identifying and synthesizing novel peptides and providing specialized testing services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phoenix Pharmaceutical.